Advanced Chemotherapy Technologies (ACT), a medical device startup developing a way to improve the treatment of pancreatic cancer, has added $2.5 million in funding to support clinical testing of its technology.
ACT device, code-named ACT-IOP-003.
ACT photos
The technology of Raleigh-based ACT is a drug delivery system. The device, code-named ACT-IOP-003, is about the size of a quarter. Implanted in the pancreas, it employs a technique called iontophoresis, which involves running a mild electric current. That current drives gemcitabine, a type of chemotherapy, into the tumor. This approach is intended to be a more targeted way of delivering a drug to the spot where it’s needed.
Investors pour $8M into Raleigh medical device startup; its drug delivery tech traces roots to UNC-CH wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.